Evidence map›Paper›PMID 40957874›Full record

ArticleCommunications biology2025

Cancer-associated fibroblasts shape the formation of budding cancer cells at the invasive front of human colorectal cancer.

Juan L García-Rodríguez, Ulrik Korsgaard, Stine M Vissing, Thea Petersen Paasch, Mariana Semenova, Simon L Vendelbo, Eva F Jensby, Hannah L Williams, Paul Vinu Salachan, Camilla Blunk Brandt and 7 more

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Juan L García-RodríguezDepartment of Biomedicine, Aarhus University, Aarhus, Denmark. juanlgr@biomed.au.dk.ORCID http://orcid.org/0000-0002-1818-1781
Ulrik KorsgaardDepartment of Clinical Pathology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark.ORCID http://orcid.org/0000-0002-1730-388X
Stine M VissingDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Thea Petersen PaaschDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0009-0007-3793-4877
Mariana SemenovaDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Simon L VendelboDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Eva F JensbyDepartment of Molecular Medicine, Aarhus University Hospital (AUH), Aarhus, Denmark.ORCID http://orcid.org/0009-0003-6871-4982
Hannah L WilliamsInstitute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland.ORCID http://orcid.org/0000-0003-0434-3900
Paul Vinu SalachanDepartment of Molecular Medicine, Aarhus University Hospital (AUH), Aarhus, Denmark.ORCID http://orcid.org/0000-0002-8179-5989
Camilla Blunk BrandtDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0003-3115-8591
Jacob HanimannInstitute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland.ORCID http://orcid.org/0000-0003-3156-0441
Lin LinDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-7546-4948
Inti ZlobecInstitute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland.
Karina D SørensenDepartment of Molecular Medicine, Aarhus University Hospital (AUH), Aarhus, Denmark.ORCID http://orcid.org/0000-0002-4902-5490
Jørgen KjemsDepartment of Molecular Biology and Genetics (MBG), Aarhus University, Aarhus, Denmark.
Henrik HagerDepartment of Pathology, Aarhus University Hospital, Aarhus, Denmark.
Lasse S KristensenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark. lasse@biomed.au.dk.ORCID http://orcid.org/0000-0002-5980-7939

Funding

Kræftens Bekæmpelse (Danish Cancer Society) R304-A17698Lundbeckfonden (Lundbeck Foundation) R307-2018-3433Novo Nordisk Fonden (Novo Nordisk Foundation) NNF20SA0061466
6 · The paper itself

Abstract

The formation of budding cancer cells at the invasive front of solid tumors is one of the first steps of metastasis. However, this process is still incompletely elucidated. Here, we used spatial molecular imaging to disentangle the complex interactions between cancer cells and the tumor microenvironment at the invasive front of colorectal tumors. Employing a 1000-plex gene panel, we defined all major cell types in tumors and adjacent normal tissue with accurate spatial information. Individual cancer cell clusters were located together, consistent with an expected mutation- and epigenetic-driven clonal evolution. However, cancer cell clusters encompassing budding cells exhibited a markedly different spatial distribution as they also contained cells that were scattered around the periphery of the main cancer cell masses. Moreover, these cells were frequently in contact with cancer-associated fibroblasts (CAFs) and underwent broad gene expression changes, mainly related to epithelial-mesenchymal transition (EMT), remodeling of the extracellular matrix (ECM), and migration. In addition, we defined an 11-gene signature (TYK2, IL2RG, KRT17, HLA-B, NPPC, WIF1, IL32, B2M, CCND1, CRIP1, ITGB1), which characterizes cancer cells en route to metastasis and is associated with inferior outcomes. Collectively, our findings suggest that CAFs induce pro-invasive gene expression changes involved in EMT, ECM remodeling, and migration.

Indexed as

Cancer-Associated FibroblastsColorectal NeoplasmsCell Line, TumorCell MovementEpithelial-Mesenchymal TransitionExtracellular MatrixFemaleGene Expression Regulation, NeoplasticHumansNeoplasm InvasivenessTumor Microenvironment

Identifiers

PMID40957874
PMCPMC12441128

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.